Catalyst Wire Dossier Catalyst Wire Dossier

CEFEPIME HYDROCHLORIDE AND DEXTROSE

CEFEPIME HYDROCHLORIDE · B. Braun Medical Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for CEFEPIME HYDROCHLORIDE AND DEXTROSE, covering 2010-05-06 to 2026-04-07. Get the full timeline:

Most recent: FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)

See pricing